Latest News in the pharma Industry

Top Stories

Novartis to Acquire Dermatology Company Fougera

Novartis to Acquire Dermatology Company Fougera

7 May 2012

Sandoz, the generics division of Novartis, is to acquire dermatology specialist Fougera at a transaction value of $1.525 billion.

Read more 
Sartorius Stedim Biotech Signs Sales Agreement with c-LEcta

Sartorius Stedim Biotech Signs Sales Agreement with c-LEcta

4 May 2012

The two firms have signed a worldwide sales and distribution agreement for c-LEcta’s proprietary Serratia marcescens nuclease for biopharmaceutical applications.

Read more 
GSK & Yale Team up for Drug Discovery

GSK & Yale Team up for Drug Discovery

3 May 2012

GSK and Yale will work together to develop an entirely new class of drugs based on PROTACs technology.

Read more 
Watson to Become Third Largest Global Generics Company Following Actavis Takeover

Watson to Become Third Largest Global Generics Company Following Actavis Takeover

2 May 2012

Watson Pharmaceuticals and Actavis Group have announced that Watson is buying the generic drugmaker.

Read more 
NHS Restructuring May Affect UK Pharma

NHS Restructuring May Affect UK Pharma

2 May 2012

An expert has claimed that the NHS overhaul taking place in England will have a knock-on effect on the pharmaceutical industry.

Read more 
Mergers & Acquisitions Activity 'Lower Than Expected' in 2011

Mergers & Acquisitions Activity 'Lower Than Expected' in 2011

2 May 2012

The latest report from BioWorld reveals that M&A activity was more subdued than expected in 2011, while the number of biopharmaceutical collaborations declined.

Read more 
Jazz Pharmaceuticals to Acquire EUSA Pharma

Jazz Pharmaceuticals to Acquire EUSA Pharma

2 May 2012

Jazz Pharmaceuticals and EUSA Pharma have announced that Jazz Pharmaceuticals has agreed to acquire the specialty pharmaceutical company for $650 million in cash and a potential $50 million milestone payment.

Read more 
UK Pharma Industry to Benefit from First Cloud Service

UK Pharma Industry to Benefit from First Cloud Service

27 Apr 2012

BT's new cloud-based service could help to reduce research costs and accelerate the development of new drugs.

Read more 
ARTES Announces Strategic Collaboration Deal for Vaccine Development

ARTES Announces Strategic Collaboration Deal for Vaccine Development

25 Apr 2012

Under the terms of the long-term research collaboration ARTES is responsible for delivery of the production cell lines and processes to Crucell.

Read more 
AstraZeneca to Acquire Ardea Biosciences

AstraZeneca to Acquire Ardea Biosciences

25 Apr 2012

AstraZeneca is to acquire biotechnology firm Ardea Biosciences for $1.26 billion. The transaction is expected to complete in the second or third quarter of 2012.

Read more 
Nestle to Buy Pfizer's Nutrition Business

Nestle to Buy Pfizer's Nutrition Business

25 Apr 2012

Pfizer has agreed to sell its Pfizer Nutrition to Nestle for $11.85bn.

Read more 
Harlan & Ipsen Ink Drug Development Services Deal

Harlan & Ipsen Ink Drug Development Services Deal

25 Apr 2012

The two companies have entered into a three-year programme on the development of early preclinical stage drug candidates.

Read more